Citadel Advisors’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.74M Sell
276,200
-70,300
-20% -$633K ﹤0.01% 6386
2025
Q4
$3.7M Sell
346,500
-175,400
-34% -$1.93M ﹤0.01% 4794
2025
Q3
$6.5M Sell
521,900
-115,300
-18% -$1.18M ﹤0.01% 3902
2025
Q2
$6.51M Buy
637,200
+198,100
+45% +$1.74M ﹤0.01% 3677
2025
Q1
$3.47M Buy
439,100
+314,800
+253% +$3.87M ﹤0.01% 4515
2024
Q4
$976K Buy
124,300
+17,800
+17% +$89.3K ﹤0.01% 7077
2024
Q3
$335K Buy
106,500
+27,300
+34% +$80.3K ﹤0.01% 9090
2024
Q2
$224K Buy
79,200
+45,000
+132% +$321K ﹤0.01% 9692
2024
Q1
$539K Sell
34,200
-5,700
-14% -$96.4K ﹤0.01% 8223
2023
Q4
$784K Buy
39,900
+19,200
+93% +$334K ﹤0.01% 7176
2023
Q3
$422K Sell
20,700
-3,800
-16% -$95.5K ﹤0.01% 8439
2023
Q2
$716K Buy
24,500
+100
+0.4% +$2.74K ﹤0.01% 7142
2023
Q1
$685K Sell
24,400
-6,800
-22% -$175K ﹤0.01% 7624
2022
Q4
$578K Sell
31,200
-4,400
-12% -$75.4K ﹤0.01% 7940
2022
Q3
$561K Buy
35,600
+100
+0.3% +$2.25K ﹤0.01% 8207
2022
Q2
$896K Sell
35,500
-181,500
-84% -$5.43M ﹤0.01% 7273
2022
Q1
$7.83M Buy
217,000
+98,800
+84% +$4.86M ﹤0.01% 3356
2021
Q4
$9.06M Buy
118,200
+400
+0.3% +$35.3K ﹤0.01% 3240
2021
Q3
$11.3M Buy
117,800
+35,100
+42% +$3.83M ﹤0.01% 2856
2021
Q2
$8.82M Sell
82,700
-56,000
-40% -$5.51M ﹤0.01% 3289
2021
Q1
$12.4M Buy
138,700
+77,012
+125% +$8.48M ﹤0.01% 2660
2020
Q4
$6.2M Sell
61,688
-30,012
-33% -$2.24M ﹤0.01% 3324
2020
Q3
$4.48M Buy
91,700
+43,400
+90% +$2.08M ﹤0.01% 3318
2020
Q2
$1.97M Buy
48,300
+32,800
+212% +$942K ﹤0.01% 4608
2020
Q1
$239K Buy
+15,500
New +$326K ﹤0.01% 7710

Other funds holding CRNC

Citadel Advisors's CRNC Position: Q1 2026 in Review

Citadel Advisors reduced its Cerence (CRNC) stake by 93% in Q1 2026, selling an estimated $7.47M and leaving 62,718 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #9840.

Citadel Advisors first reported a position in CRNC in Q4 2019 and has held it in 25 quarters since. The position peaked at $14.7M in Q1 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Citadel Advisors held 62,718 shares of Cerence worth $396K as of Q1 2026.
  • Citadel Advisors sold 829,151 Cerence shares in Q1 2026, an estimated $7.47M.
  • Cerence made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9840 holding.
  • Citadel Advisors first reported a position in Cerence in Q4 2019 and has held it in 25 quarters since.
  • Citadel Advisors's Cerence position peaked at $14.7M in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.